Novavax, Inc.

NASDAQ:NVAX  
131.79
+10.79 (+8.92%)
4:03:29 PM EDT: $131.05 -0.74 (-0.56%)
Products, Strategic Combinations

Endo Announces Fill-Finish Manufacturing And Services Agreement For Novavax Covid-19 Vaccine Candidate

Published: 09/25/2020 11:10 GMT
Novavax, Inc. (NVAX) - Endo Announces Fill-finish Manufacturing and Services Agreement for Novavax Covid-19 Vaccine Candidate.
Endo International Plc - Financial and Other Terms of Agreement Were Not Disclosed.
Endo International Plc - Par Sterile's Rochester Facility Has Begun Production of Nvx-cov2373 Final Drug Product.
Endo International Plc - Interim Data for Trials is Expected Before End of 2020.
Endo International Plc - Par Sterile Will Also Fill-finish Nvx-cov2373 Vaccine Intended for Commercial Distribution in United States.